MENU
ACOG
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Alpha Cognition (ACOG) Ownership - Who owns Alpha Cognition?
Alpha Cognition Inc is a commercial-stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI), for which there are currently no approved treatment options... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
81.06M
P/E Ratio
N/A
Total Cash
3.67M
Projected Growth
N/A
Total Debt
2.21M
Revenue
N/A
Risk (Beta)
2.49
Dividend Yield
N/A
Total Cash/Share
0.23
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ACOG
Capitalization
81.1M
P/E Ratio
N/A
Risk (Beta)
2.49
Dividend Yield
N/A
Total Cash
3.67M
Total Cash/Share
0.23
Total Debt
2.21M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-2.92M
P/B Ratio
1.96
Cash Flow
N/A
Earnings
-3.03
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
49.1M
Current Ratio
1.50
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-14.46M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-437.62
Shares Held By Institutions
34.8M
Shares Outstanding - Current
16M
Total Liabilities
7.95M
Total Volume MTD
N/A
Value
1
Gain YTD
-14.092
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information